News About: Pharm. Industry
345 items to be re-examined by 2010
The Korea Food and Drug Administration said a total of 345 drugs will be subject to re-examination for the next four years.
Under the current pharmaceutical affairs law, pharmaceutical firms will have to make ensur...
Daewoong and wholesalers likely to solve problems this month.
Daewoong and drug wholesalers have disputed on the distribution margins granted to Daewoong's associated wholesalers, which seems to be solved smoothly between two sides.
The wholesaler group took an executive meet...
KFDA approved a 24 hour sustained ADHD drug.
The KFDA approved a 24 hour sustained ADHD drug named Strattera (atomoxetine hydrochloride) filed by Lilly Korea.
According to Lilly Korea on Oct. 11, Strattera is a 24 hour effective drug for the treatment of ADHD...
Novartis Korea launches fund-raising campaign for CML patients
Novartis Korea said it has launched a campaign for the fund-raising to support Korean patients with chronic myeloid leukemia (CML) and metastatic gastrointestinal stromal tumors (GIST) as part of its plan to commemora...
KFDA to face lawsuit
12 pharmaceutical firms, including Dong-A Pharm and Whanin Pharm, said recently it will file a suit with a Seoul court against the Korea Food and Drug Administration (KFDA) for its improper license cancellation of the...
Many Korean pharmaceutical research institutes moving into Seoul.
Most of local pharmaceutical research institutes are moving into the Gooro digital research industrial park in Seoul because of the researcher's preference to living in Seoul and difficulty in recruiting researchers i...
AstraZeneca's Crestor monthly sales hit 3 billion wonAstraZeneca Korea said on October 9 it sold 3.0 billion worth of Crestor (rosuvastatin) last month, setting a new monthly sales record.
In 2005, the company said its Crestor...
|
Distrust in generic drugs will likely dampen pharmaceutical industry
Korea's generic drug makers are likely to lose their momentum, as the Korea Food and Drug Administration revealed a series of reports on manipulated test results of generic drugs whose efficacy is not equivalent to th...
Controversy looms over unified distribution
Tension is running high again between drug makers and wholesalers as 30 pharmaceutical firms, who received the second administrative disposition on suspicion of violating the current regulation to prohibit a direct de...
Pharmaceutical industry calls for promotion of generic drugs
Domestic pharmaceutical industry has called on the government to promote the use of generic drugs, fearing that most people are shocked by the recent reports of manipulated test results for generic drugs whose efficac...
